CBG logo
Focused certification exam prep
Start practice

CBG Training

TL;DR
  • CBG here means Clinical Biochemical Genetics, certified through the American Board of Medical Genetics and Genomics (ABMGG).
  • The blueprint has 15 content categories; Amino acids (15%) and Lipids (13%) carry the most weight.
  • Organic acids (12%) and Lysosomes (12%) together equal roughly a quarter of the exam's content emphasis.
  • Laboratory content (8%) covers QA/QC, artifact, techniques, and regulations, so bench interpretation skills count.

What CBG Training Actually Covers

Training for Clinical Biochemical Genetics is not the same as cramming for a generic multiple-choice test. The credential, issued by the American Board of Medical Genetics and Genomics (ABMGG), is built around the biochemical basis of inherited metabolic disease: recognizing a biochemical pattern, tracing it to an enzyme or transporter defect, and understanding how the laboratory finds and confirms it. If you are still orienting yourself, start with What Is CBG Certification? and What Does CBG Stand For?, then return here for the training plan.

Effective training therefore has two intertwined tracks. The first is knowledge of disease categories: what each disorder is, which metabolites accumulate or run short, and what the clinical consequences are. The second is laboratory fluency: how analytes are measured, how results can mislead, and how quality systems and regulations shape what a laboratory can report. The official blueprint treats both as examinable, which is why this guide organizes training around the blueprint rather than around a generic textbook order.

Identity check: "CBG" has several unrelated meanings in other fields. Everything on this page refers only to Clinical Biochemical Genetics and the ABMGG biochemical genetics blueprint. Do not mix in material from any other credential that shares the acronym.

The Training Pathway Behind the Credential

Certification exams in this field sit at the end of structured, supervised training, not at the start. Candidates typically accumulate clinical and laboratory exposure to inborn errors of metabolism over a sustained period before sitting the examination. The exact eligibility rules, accepted training routes, and application steps are covered in CBG Requirements 2026: Eligibility, Prerequisites & How to Qualify; confirm the current details directly with ABMGG, since they govern whether your training counts.

What matters for exam-focused training is the division between two kinds of learning:

  • Experiential training builds judgment: reviewing real patient results, newborn screening follow-up, confirmatory testing logic, and case discussion with colleagues.
  • Blueprint-aligned review fills the gaps that daily work leaves behind. Most trainees see common disorders constantly and rare ones almost never, yet the exam samples across all fifteen categories.

The blueprint categories are exam objectives, not a substitute for broader preparation resources or performance-only training. Treat them as a checklist for coverage, and use clinical rotations, laboratory work, and standard references to build depth.

Reading the Blueprint as a Training Syllabus

The ABMGG Biochemical Genetics Blueprint and Content Codes (effective August 2025) lists fifteen content topics with approximate percentages. The percentages published in the source sum to 102% because of a discrepancy in the source total; this site reports them as published rather than normalizing them. Use them as relative emphasis, not exact question counts.

Blueprint CategoryApprox. WeightTraining Emphasis
Amino acids15%Highest priority
Lipids13%High priority
Organic acids12%High priority
Lysosomes12%High priority
Carbohydrates10%Substantial
Laboratory8%Substantial, often undertrained
Cofactors7%Moderate
Mitochondria7%Moderate
Peroxisomes3%Targeted review
Purines and pyrimidines3%Targeted review
Transport3%Targeted review
Metals3%Targeted review
Other disease category3%Targeted review
Neurotransmitters2%Light review
Creatine1%Light review

For a category-by-category walkthrough, see CBG Exam Domains 2026: Complete Guide to All 15 Content Areas. The sections below translate the weights into training decisions.

The Heavy Domains: Where Training Time Pays Most

Four categories (Amino acids, Lipids, Organic acids, and Lysosomes) account for the largest share of the blueprint. Training should be deepest here, and the content is highly pattern-driven, which rewards repeated exposure to analyte profiles.

Amino acids (15%)

The largest single category. Know each disorder's characteristic metabolite pattern and the enzyme or pathway at fault.

  • PKU and hyperphenylalaninemia, and the tyrosinemias
  • Glycine encephalopathy/hyperglycinemia
  • MSUD and disorders of branched-chain amino acids
  • Homocystinuria, disorders of sulfur amino acids, and re-methylation defects
  • Urea cycle defects, plus serine and other disorders

Organic acids (12%)

Training here is about distinguishing look-alike profiles and knowing which acylcarnitine or urine organic acid markers point where.

  • Methylmalonic acidemia (excluding cobalamin defects) and propionic acidemia
  • 3-MCC deficiency and other C5OH-related disorders
  • IVA and other C5-related disorders
  • Glutaric acidemia type I
  • Disorders of ketone body metabolism (HMG-CoA lyase, SCOT)
  • Other disorders, including glutathione synthetase deficiency, ECHS1, and non-type 1 3-methylglutaconic aciduria

Lipids (13%)

Three clusters: fatty acid oxidation, hyperlipidemias, and cholesterol/bile acid metabolism.

  • Fatty acid oxidation disorders across short-, medium-, and long-chain defects and multiple acyl-CoA dehydrogenase deficiency (GA2)
  • Hyperlipidemias, including Tangier disease
  • Cholesterol metabolism disorders such as Smith-Lemli-Opitz and Niemann-Pick C, plus bile acid disorders

Lysosomes (12%)

Organize by disease family rather than memorizing a flat list.

  • Mucopolysaccharidoses (Types I, II, III, IV, VI, VII)
  • Sphingolipidoses: Gaucher, Fabry, GM2 gangliosidoses (Tay-Sachs and variants, Sandhoff), Krabbe, Niemann-Pick types A and B, GM1 gangliosidosis
  • Multiple enzyme deficiencies: mucolipidoses ML-II and ML-III, multiple sulfatase deficiency
  • Other: Pompe, cystinosis, and NCL

Key Takeaway

Train the four heavy categories first and revisit them most often. Build a one-line "metabolite signature" for every named disorder so you can reason from a lab pattern to a diagnosis, not just recite definitions.

Mid-Weight Domains That Carry the Pattern Recognition

Carbohydrates (10%)

This category rewards pathway-level understanding. Cover glycogenoses (excluding GSD II, which is assigned to the lysosomal category), disorders of glycolysis, gluconeogenesis defects including fructose-1,6-bisphosphatase deficiency, galactose and fructose metabolism disorders, congenital disorders of glycosylation, and others such as the pentose phosphate pathway. Note the explicit boundary: Pompe disease is tested under Lysosomes, so do not duplicate your effort or, worse, misfile it mentally.

Cofactors (7%)

Cofactor disorders connect back to the amino acid and organic acid categories, which makes them efficient to study alongside those topics. Cover cobalamin, biotin, molybdenum, folate, pyridoxine, and biopterin, plus other vitamin-related conditions including riboflavin, niacin, and thiamine. Pay particular attention to the line the blueprint draws: methylmalonic acidemia is listed as "excluding cobalamin defects," which signals that cobalamin processing defects are tested in the cofactor category.

Mitochondria (7%)

Training should span clinical presentation and laboratory findings: mitochondrial myopathies (including Leigh syndrome and adult presentations), electron transport chain function and assembly disorders, mitochondrial DNA mutation disorders, mtDNA maintenance and depletion syndromes, and entities such as MELAS. Because overlap between nuclear and mitochondrial genetics is a recurring source of confusion, practice distinguishing inheritance patterns alongside biochemistry.

Why cross-category links matter: Several blueprint categories share biology. Cofactor defects mimic organic acidemias, fatty acid oxidation disorders overlap with carnitine transport, and mitochondrial disease intersects with many metabolic pathways. Studying the links reduces the total volume you must memorize.

Small Domains That Still Appear on the Exam

Categories with weights of 1% to 3% are easy to neglect, and that is a mistake: they are compact, finite, and quick to master, so a modest investment secures reliable points. Each is well bounded by the blueprint:

  • Peroxisomes (3%): biogenesis disorders including Zellweger syndrome; single-enzyme disorders including X-linked adrenoleukodystrophy; others including Refsum and infantile Refsum disease.
  • Purines and pyrimidines (3%): Lesch-Nyhan disease, adenosine deaminase deficiency, and other purine disorders; UMP synthase deficiency and other pyrimidine disorders.
  • Transport (3%): dibasic aminoaciduria (cystinuria, lysinuric protein intolerance), other amino acid transport disorders, plus glucose, carnitine, and other transport defects.
  • Metals (3%): copper disorders (Wilson disease, Menkes disease), iron, zinc, and others.
  • Neurotransmitters (2%): SSADH deficiency, disorders of dopamine synthesis, and others including GABA metabolism.
  • Creatine (1%) and Other disease category (3%): short, targeted review.

A practical approach is a single compact reference sheet for these categories. The CBG Cheat Sheet 2026: One-Page Review of Must-Know Facts is a useful companion for this kind of rapid review.

Laboratory Training: QA/QC, Artifact, Techniques, Regulations

At roughly 8%, the Laboratory category is larger than several disease categories, and it is where clinically focused trainees often have the thinnest preparation. The blueprint divides it into four strands:

Laboratory (8%)

Know how a result is produced, how it can go wrong, and what rules govern reporting.

  • QA/QC: quality assurance and control concepts as applied to biochemical genetic testing
  • Artifact: how specimen handling, diet, medications, and analytical interference can create misleading profiles
  • Techniques: the analytical methods used to measure metabolites and enzymes
  • Regulations: the regulatory framework governing clinical laboratory testing

Artifact deserves special attention. A candidate who can tell a true metabolic signature from a specimen- or treatment-related distortion demonstrates exactly the interpretive judgment this credential is designed to assess. If your training site limits your exposure to the analytical side, seek out supervised bench time or structured review of method principles.

Sequencing Your Preparation Around the Blueprint

Generic scheduling advice matters less than ordering topics so that related biology reinforces itself. The timeline below is one reasonable arrangement; adjust the pace to your own baseline. For a fuller plan, see the CBG Study Guide 2026: How to Pass on Your First Attempt.

Block 1

Amino acids and cofactors

  • Anchor the largest category first
  • Add cofactors immediately, since cobalamin, biotin, and pyridoxine defects mimic amino and organic acid profiles
Block 2

Organic acids and lipids

  • Pair organic acidemias with fatty acid oxidation disorders, which share acylcarnitine reasoning
  • Then cholesterol and bile acid disorders
Block 3

Lysosomes and carbohydrates

  • Group by disease family, and keep the Pompe and GSD II boundary straight
  • Cover glycogenoses and congenital disorders of glycosylation
Block 4

Mitochondria, peroxisomes, and the small categories

  • Mitochondrial disease alongside peroxisomal biogenesis and single-enzyme disorders
  • Sweep through transport, metals, purines/pyrimidines, neurotransmitters, creatine
Block 5

Laboratory and mixed review

  • QA/QC, artifact, techniques, regulations
  • Full-blueprint practice questions to expose weak spots

Reserve the last block for mixed practice. You can build familiarity with question style using the CBG practice test on the main site, and revisit weak categories after each session.

Timing Your Training to the Exam Cycle

Training only becomes actionable when you know the calendar. ABMGG has approved a transition to an annual certifying examination schedule, and biochemical genetics specialties are offered in odd years. The next Clinical Biochemical Genetics exam is identified as August 2027, with ABMGG announcing certification exams for August 11-14, 2027. Work backward from that window when planning your preparation, and check CBG Exam Dates 2026: Testing Windows, Deadlines & Scheduling for current scheduling guidance.

Note that this site does not publish a question count, timer length, fee, or passing score for the exam, because those details were not established from the official source content we reviewed. For cost and scoring discussions, see CBG Certification Cost 2026: Complete Pricing Breakdown and CBG Passing Score 2026: Exactly What You Need to Pass, and verify any figures directly with ABMGG before relying on them.

Key Takeaway

With the exam offered in odd years and the next sitting identified as August 2027, there is room for a deliberate, unhurried training arc. Use the lead time to build clinical and laboratory depth first, and reserve the final months for blueprint-aligned review and practice questions.

Where Trained Clinical Biochemical Geneticists Work

Training for this credential feeds careers centered on inherited metabolic disease. Typical settings include clinical biochemical genetics laboratories, academic medical centers with metabolic or genetics services, children's hospitals, and reference laboratories that perform specialized metabolite and enzyme testing. Roles generally involve interpreting results, advising clinicians, directing or supervising laboratory testing, and contributing to newborn screening follow-up.

If you are weighing the investment, our analyses of whether the CBG certification is worth it and the CBG jobs landscape discuss career outcomes in more detail, and the CBG salary guide addresses compensation. We do not quote specific earnings here because we cannot verify them against the official source. For a candid look at preparation demands, read How Hard Is the CBG Exam? and the CBG pass rate discussion.

Frequently Asked Questions

What does CBG training prepare me for?

It prepares you for certification in Clinical Biochemical Genetics through the American Board of Medical Genetics and Genomics (ABMGG), which assesses knowledge of inherited metabolic disease and the laboratory methods used to detect and interpret it.

Which topics should training prioritize?

The blueprint weights Amino acids at 15%, Lipids at 13%, and both Organic acids and Lysosomes at 12%. These four categories merit the deepest and most repeated review, followed by Carbohydrates at 10% and Laboratory at 8%.

Is the Laboratory category worth serious study time?

Yes. At approximately 8% it outweighs several disease categories. It covers QA/QC, artifact, techniques, and regulations, and artifact recognition in particular reflects the interpretive judgment the credential is designed to assess.

When is the next exam and how should I time my training?

The next Clinical Biochemical Genetics exam is identified as August 2027, since biochemical specialties are offered in odd years. Plan your training so that blueprint review and practice questions occupy the final stretch before that window.

Do the blueprint percentages add up to 100%?

No. The published approximate percentages total 102% because of a discrepancy in the source. They are best read as relative emphasis rather than exact question counts, and this site reports them as published without normalizing them.

For a broader introduction to the credential, see CBG Certification, and when you are ready to test your knowledge against realistic questions, try the CBG Exam Prep practice tests.

Ready to pass your CBG exam?

Put this into practice with free CBG questions across every exam domain.